Patches and Still are flushed. This is too dangerous for Still. He jumped off that bridge with Patches.
Frederick, Maybe, all is speculation so far. ACRX has no partnerships yet in US. I like it, but don't know if S. Shively will bite as of yet.
Yes, I saw BEAV. He may have had DRTX or may still have it. He is currently on GERN board fairly often. I did a couple GERN trades, following Beavs lead, but generally cancer companies make me a little skittish.
I like the Glucagon injector which may be ready for NDA filing in a year. All those Epipens we buy for kids each year whether they are used or not for severe allergy (maybe BIODEL can sell a bunch of these Glucagon kits each year if ever approved). The insulin projects look interesting, reducing the amount of insulin needed per day.
You are feeling heat now because you short for 7.48 per your last posting. Well, you may have to kick PATCHES tonight. I hope you two make it out of the fire in time and stop smoking PATCHES kibble.
Look at the Silenor slides. This looks interesting, Managed care - 58 million covered lives added. Also, Treximet sales for 2013 were $78 million. Both Silenor and Treximet should increase, IMO.
maxx, Horizon has a site to help coordinate benefits. The department helps sort through insurance. They have have help for patients that can't afford. HZNP drugs are not on all formularies, nor is Treximet. Some tier 2 patients are already on the drug, so that should continue.
They won't in every case. You are correct about price from what I have been able to look at. Some of these patients can take Treximet and get easily covered. These patients have in some cases not had relief from straight sumatriptan or others. Drysdale will likely do what HZNP has done. Prescriptions Made Easy, and also offer copay coupons like SNTS did.